Discounted Cash Flow
Cormedix Inc.
—
—
Average annual growth rates
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Endpoint CAGR (better for long term trend)
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Projected growth rate
—
—
%
%
Historical inputs (10 fiscal years)
| YEAR | Sales | Net Income | Free Cash Flow | Net Margin | EPS (diluted) |
|---|---|---|---|---|---|
| 2016 | $224.1k | $-24.6m | $-22.3m | -10996.5% | $-0.65 |
| 2017 | $329.3k (47.0%) | $-33.0m (-33.9%) | $-28.7m (-28.7%) | -10023.4% (8.8%) | $-0.60 (7.7%) |
| 2018 | $429.8k (30.5%) | $-26.8m (18.7%) | $-23.7m (17.4%) | -6242.4% (37.7%) | $-1.51 (-151.7%) |
| 2019 | $283.3k (-34.1%) | $-16.4m (38.8%) | $-15.1m (36.5%) | -5801.3% (7.1%) | $-1.80 (-19.2%) |
| 2020 | $239.2k (-15.5%) | $-22.0m (-34.0%) | $-22.1m (-46.3%) | -9207.7% (-58.7%) | $-0.77 (57.2%) |
| 2021 | $190.9k (-20.2%) | $-28.2m (-28.1%) | $-22.6m (-2.3%) | -14774.7% (-60.5%) | $-0.75 (2.6%) |
| 2022 | $65.4k (-65.7%) | $-29.7m (-5.3%) | $-24.6m (-8.8%) | -45409.9% (-207.3%) | $-0.74 (1.3%) |
| 2023 | $2.7m (4000.2%) | $-46.3m (-56.0%) | $-38.7m (-57.6%) | -1727.9% (96.2%) | $-0.91 (-23.0%) |
| 2024 | $43.5m (1521.0%) | $-17.9m (61.3%) | $-50.7m (-31.0%) | -41.2% (97.6%) | $-0.30 (67.0%) |
| 2025 | $311.7m (617.0%) | $163.1m (1009.4%) | $172.8m (440.6%) | 52.3% (226.8%) | $2.25 (850.0%) |
Base FCF: — (latest fiscal year)
Discount rate: % —
Terminal growth: —
Projection period: — years
Alt A decline yrs:
Alt B total yrs:
Projected cash flows
| Year | Projected cash flow | Discount Factor | Present Value |
|---|
PV of projected FCF: —
Terminal FCF: —
Terminal value: —
PV of terminal value: —
Enterprise value (DCF): —
Current price: —
—Alternative DCF Models
| Model | Fair Value | Upside | PV(FCFs) | PV(Terminal) | Total Years |
|---|---|---|---|---|---|
| Standard (10yr→TV) | — | — | — | — | 10 + TV |
| Alt A (Gradual Decline) | — | — | — | — | — |
| Alt B (30yr Hard Stop) | — | — | — | N/A | — |
This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.